Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherClinical Investigations

99mTc-Aprotinin Scintigraphy in Amyloidosis

Bente K. Schaadt, Helle W. Hendel, Peter Gimsing, Viggo Jønsson, Heidi Pedersen and Birger Hesse
Journal of Nuclear Medicine February 2003, 44 (2) 177-183;
Bente K. Schaadt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helle W. Hendel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Gimsing
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Viggo Jønsson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heidi Pedersen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Birger Hesse
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    An 86-y-old woman (patient 1) with IgGκ multiple myeloma developed carpal tunnel syndrome, progressive submandibular masses, and swelling of tongue. At time of scintigraphy, patient did not have abdominal symptoms but later developed severe constipation due to intestinal amyloidosis. 99mTc-Aprotinin scintigrams show pathologic uptake in heart and parts of intestine (A, abdominal anterior projection), both hands (B, dorsal view), and tongue and submandibular glands (C, left lateral projection of head).

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    A 50-y-old man (patient 14) suffering from severe polyneuropathy during last year, slight functional dyspnea, and coughing. Biopsy of sural nerve showed unspecific axonal atrophy. His mother had died from polyneuropathy and amyloid cardiomyopathy. Scintigram shows pleural and cardiac accumulations of aprotinin (A, anterior view). (B) SPECT tomograms of chest show pronounced aprotinin uptake in interventricular septum and less pronounced uptake in lateral wall and apex of heart. VLA = vertical long axis; HLA = horizontal long axis; SA = short axis.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    A 64-y-old man (patient 5) with renal AL amyloidosis. Whole-body scintigram shows pathologic uptake in heart, liver, and right lung or pleura (anterior view). Patient had no symptoms from heart at time of scintigraphy but died of heart failure 8 mo later.

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    Whole-body scintigram shows pathologic uptake in left maxillary sinus in 78-y-old woman (patient 6) with plasmacytoma. Several accumulations in calvarium, lungs or pleura, left femur, and shoulder are also revealed. Patient had no symptoms from these sites, but physical examination of calvarium revealed palpable masses and biopsy confirmed amyloid. (A) Anterior view. (B) Posterior view.

  • FIGURE 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5.

    A 62-y-old man (patient 3) with plasmacytoma in upper mediastinum with destruction of sternum and extrathoracic component. CT scan also showed tumor in region of left os zygomaticus. 99mTc-Aprotinin scintigram reveals pathologic uptake in upper mediastinum, left eye region, left shoulder, and liver (anterior view).

Tables

  • Figures
    • View popup
    TABLE 1

    Characteristics of 23 Consecutive Patients with Known or Suspected Amyloidosis and Findings on 99mTc-Aprotinin Scintigraphy

    Patient no.SexAge (y)Type of amyloidosis/coexisting malignant disease and clinical conditions99mTc-Aprotinin accumulations on scintigraphyBiopsy or autopsy positive or negative*Symptoms on scintigraphy†
    1F86AL amyloidosis/IgGκ multiple myelomaHands+
    Tongue++
    Submandibular glands++
    Heart, intestines−
    2M39AL amyloidosis renis/nephrotic syndrome, multiple myeloma (κ light-chain disease)Heart++
    Paraaortic lymph nodes+−
    Liver+−
    Spleen+−
    3M62AL amyloidosis/plasmacytoma with amyloidosis, multiple myeloma (λ light-chain disease)Left eye region+‡
    Upper mediastinum++
    Left shoulder+
    Liver−
    4M59AL amyloidosis/IgGκ M component, MGUSHeart, liver−
    Spleen−
    ——+ rectum, + bone marrow, + lip
    5M64AL amyloidosis renis/(λ light chain in urine)Heart+−
    Right lung/pleura+−
    Liver+−
    Spleen+−
    6F78AL amyloidosis/initially plasmacytoma, multiple myeloma (κ light-chain disease)Both pleura/lungs−
    Left maxillary sinus++
    Calvarium++
    Right shoulder+−
    Left femur−
    7F66AL amyloidosis renis/multiple myeloma IgAλLungs−
    Liver, intestines−
    8F70Clinically evident amyloidosis/multiple myeloma (λ light-chain disease)Liver, spleen−
    9F56Localized amyloidosis in plica vocalis/no myelomaLiver−−
    —+ plica vocalis+
    10F66Clinically evident amyloidosis/IgAλ multiple myelomaHeart+§
    Tongue+
    Liver−
    11F75AL amyloidosis renisLiver++
    Spleen−
    12F45Localized amyloidosis in biopsy of sural nerve—+ of sural nervePolyneuropathy
    13M55AL amyloidosis/IgGκ multiple myelomaHeart++¶
    14M50Hereditary amyloidosisHeart++
    Pleura, intestines−
    15M73AL amyloidosis renis/IgMκ macroglobulinemia WaldenströmLungs−
    Liver, spleen−
    Intestines−
    16F57Hereditary amyloidosisHeart+
    Lungs+
    Liver, pleura−
    17F60Clinically evident amyloidosis/IgGκ multiple myelomaLungs+
    Liver−
    18F58AL amyloidosis/macroglobulinemia Waldenström, and cold-agglutinin syndromeLiver+
    Spleen, intestines, lungs−
    All major joints+
    Metacarpophalangeal regions and fingers+ pathologic fracture of right femur, + bone marrow+
    19F58Localized amyloidosis in bronchial biopsyLungs, liver−
    20M54AL amyloidosis/IgMκLiver++
    Spleen+−
    Intestines+
    + heart,‖ + alveolar walls, + vascular walls in lungs, + bone marrow+
    21F67AL amyloidosis/nephrotic syndrome IgAλLiver+
    Spleen, lungs−
    Shoulders, nasopharynx−
    22M53AL amyloidosis/multiple myeloma, gastrointestinal and bone marrow amyloid depositsTongue+
    Pleura−
    Liver, spleen−
    23F57AL amyloidosis of lungsLungs++
    Liver−
    • ↵* Positive (+) or negative in relation to scintigraphic findings.

    • ↵† Positive (+) = symptoms on scintigraphy; negative (−) = no symptoms on scintigraphy.

    • ↵‡ Had scintigraphy performed twice within 6 mo after chemotherapy and autologous transplantation of bone marrow and had clinical, paraclinical, and scintigraphic reduction of tumor size in mediastinum.

    • ↵§ After medical treatment with alkaran and prednisolone, patient had regression of symptoms.

    • ↵¶ Had scintigraphy performed twice within 6 mo after chemotherapy and autologous transplantation of bone marrow with remission of multiple myeloma, but no change in cardiac uptake on scintigraphy or cardiac performance.

    • ↵‖ Cardiac region was not sufficiently covered by scintigraphic study.

    • MGUS = monoclonal gammopathy of unknown significance.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 44, Issue 2
February 1, 2003
  • Table of Contents
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
99mTc-Aprotinin Scintigraphy in Amyloidosis
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
99mTc-Aprotinin Scintigraphy in Amyloidosis
Bente K. Schaadt, Helle W. Hendel, Peter Gimsing, Viggo Jønsson, Heidi Pedersen, Birger Hesse
Journal of Nuclear Medicine Feb 2003, 44 (2) 177-183;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
99mTc-Aprotinin Scintigraphy in Amyloidosis
Bente K. Schaadt, Helle W. Hendel, Peter Gimsing, Viggo Jønsson, Heidi Pedersen, Birger Hesse
Journal of Nuclear Medicine Feb 2003, 44 (2) 177-183;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Transthyretin (TTR) Cardiac Amyloidosis
  • Radiolabeled Fucoidan as a P-Selectin Targeting Agent for In Vivo Imaging of Platelet-Rich Thrombus and Endothelial Activation
  • In vivo molecular imaging of peripheral amyloidosis using heparin-binding peptides
  • Role of 99mTc-DPD Scintigraphy in Diagnosis and Prognosis of Hereditary Transthyretin-Related Cardiac Amyloidosis
  • Identification and Design of Peptides as a New Drug Delivery System for the Brain
  • Radioimaging of Light Chain Amyloid with a Fibril-Reactive Monoclonal Antibody
  • Noninvasive Etiologic Diagnosis of Cardiac Amyloidosis Using 99mTc-3,3-Diphosphono-1,2-Propanodicarboxylic Acid Scintigraphy
  • Google Scholar

More in this TOC Section

  • Cardiac Presynaptic Sympathetic Nervous Function Evaluated by Cardiac PET in Patients with Chronotropic Incompetence Without Heart Failure
  • Validation and Evaluation of a Vendor-Provided Head Motion Correction Algorithm on the uMI Panorama PET/CT System
  • Prognostic Role of 68Ga-PSMA11 PET–Based Response in Patients with Prostate Cancer Undergoing Taxane-Based Chemotherapy
Show more Clinical Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire